Press Releases

Kite Pharma to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016

Conference Call and Webcast Scheduled for 4:30 PM Eastern Time

SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report fourth quarter and full year 2015 financial results on Monday, February 29, 2016 after market close, and will host a conference call to discuss financial results and provide a business update at 4:30 PM Eastern Time (1:30 PM Pacific Time).

Audio Webcast

Interested parties may access a live audio webcast of the conference call on the Investors section of Kite's website,  A replay of the webcast will be available on the website for approximately 30 days.

Dial-In Information

Live (U.S. / Canada): (877) 301-8565
Live (International): (678) 562-4240
Confirmation number: 45173015

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit Sign up to follow @KitePharma on Twitter at

CONTACT: Greg Mann

VP, Investor Relations

For Media: Justin Jackson

Burns McClellan

(212) 213-0006

Primary Logo

Source: Kite Pharma, Inc.

News Provided by Acquire Media